FR2829697B1 - Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin - Google Patents

Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin

Info

Publication number
FR2829697B1
FR2829697B1 FR0111904A FR0111904A FR2829697B1 FR 2829697 B1 FR2829697 B1 FR 2829697B1 FR 0111904 A FR0111904 A FR 0111904A FR 0111904 A FR0111904 A FR 0111904A FR 2829697 B1 FR2829697 B1 FR 2829697B1
Authority
FR
France
Prior art keywords
inflammatory
hydroxyl
treatment
steroid hormones
intestinal diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0111904A
Other languages
English (en)
Other versions
FR2829697A1 (fr
Inventor
Michel Seman
Marc Criton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories Mayoly Spindler SAS
Original Assignee
Laboratories Mayoly Spindler SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratories Mayoly Spindler SAS filed Critical Laboratories Mayoly Spindler SAS
Priority to FR0111904A priority Critical patent/FR2829697B1/fr
Priority to PCT/FR2002/003109 priority patent/WO2003024460A1/fr
Publication of FR2829697A1 publication Critical patent/FR2829697A1/fr
Application granted granted Critical
Publication of FR2829697B1 publication Critical patent/FR2829697B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0111904A 2001-09-14 2001-09-14 Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin Expired - Fee Related FR2829697B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0111904A FR2829697B1 (fr) 2001-09-14 2001-09-14 Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin
PCT/FR2002/003109 WO2003024460A1 (fr) 2001-09-14 2002-09-12 Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3-beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0111904A FR2829697B1 (fr) 2001-09-14 2001-09-14 Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin

Publications (2)

Publication Number Publication Date
FR2829697A1 FR2829697A1 (fr) 2003-03-21
FR2829697B1 true FR2829697B1 (fr) 2004-03-19

Family

ID=8867284

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0111904A Expired - Fee Related FR2829697B1 (fr) 2001-09-14 2001-09-14 Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin

Country Status (2)

Country Link
FR (1) FR2829697B1 (fr)
WO (1) WO2003024460A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20120687T1 (hr) * 2006-11-30 2012-09-30 Hunter-Fleming Limited Moduliranje metabolizma prostaglandina/ciklooksigenaze

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696934B1 (fr) * 1992-10-20 1995-06-02 Conservatoire Nal Arts Metiers Dérivés de stéroïdes naturels 3B hydroxyles ayant des propriétés de déclenchement et de stimulation de l'immunité, composition les contenant et procédé pour les obtenir.
US5763435A (en) * 1995-11-21 1998-06-09 Children's Hospital Medical Center Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders
KR100717897B1 (ko) * 1999-03-23 2007-05-14 홀리스-에덴 파마슈티칼즈, 인코포레이티드 면역 조절용 스테로이드, 특히16α-브로모에피안드로스테론의 헤미하이드레이트
WO2002024205A1 (fr) * 2000-09-19 2002-03-28 Humanetics Corporation Traitement de maladies inflammatoires du colon par l'administration de $g(d)5-androstene-3$g(b)-ol-7,17 dione et de precurseurs metabolisables de celle-ci

Also Published As

Publication number Publication date
WO2003024460A1 (fr) 2003-03-27
FR2829697A1 (fr) 2003-03-21

Similar Documents

Publication Publication Date Title
FR13C0060I2 (fr) Omega-carboxyaryldiphenyluree fluoro-subtituee pour le traitement et la prevention de maladies et d'etats pathologiques
EP1360965A4 (fr) Procedes de traitement de maladies en association avec la diminution de l'expression du gene aop-1 ou de aop-1 et remedes con us pour ces maladies
MA28689B1 (fr) Derives de pyrrozolotriazine utiles pour le traitement des troubles et maladies hyperproliferatifs associes a l'angiogenese
MA26992A1 (fr) Derives de phenethanolamine pour le traitement des maladies respiratoires
MA26951A1 (fr) Derives de pyrazole pour le traitement de maladies virales
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
EP1438062A4 (fr) Methodes et compositions pour le traitement de lesions cutanees
MA27027A1 (fr) Inhibiteur de pde4 et agent anticholinergique en association pour le traitement de maladies obstructives des voies aeriennes
DE60036968D1 (de) Adamantanderivate zur Behandlung von entzündlichen, immunologischen und kardiovaskulären Erkrankungen
FR2785521B1 (fr) Dispositif de suspension pour le traitement de prolapsus et d'incontinences urinaires
NO20031442D0 (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
EP1284728A4 (fr) Medicaments destines au traitement de l'obesite
IL245955B (en) Immunogenic compositions for the prevention and treatment of meningococcal disease
NO20022974D0 (no) Anvendelse av biologisk aktive vitamin D-forbindelser for forhindring og behandling av inflammatorisk tarmsykdom
CY2013041I2 (el) Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
MA28806B1 (fr) Derives d'arylsulfonylstilbene destines au traitement de l'insomnie et de conditions apparentees
SI1764111T1 (sl) AntidisritmiŽŤna sredstva za vaginalno dajanje za zdravljenje materniŽŤne disritmije
EP1539251A4 (fr) Compositions et methodes permettant le diagnostic et le traitement d'etats pathologiques impliquant l'angiogenese
KR970000230A (ko) 염증성 장 질환을 치료하기 위한 캅파-아편제 작용물질
EP1830873A4 (fr) Glyponectine (adiponectine glycosylee) pour le traitement de maladies et d'etats pathologiques
EP1126850A4 (fr) Traitement des affections de la retine
DZ3393A1 (fr) Procede de detection de composes apropries pour le traitement et/ou la prophylaxie de l'obesite
EP1381378A4 (fr) Compositions et methodes pour la prevention et le traitement du cancer issues d'inula britannica
EP1161255A4 (fr) Procedes et compositions pour le traitement de la dyserection

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070531